Glooko Inc has announced that it has partnered with Sanofi to integrate SoloSmart with the Glooko platform.
SoloSmart is a single piece add-on connected device intended for use with SoloStar and DoubleStar insulin injection pens which records the insulin dose, date and time of injection. The data will appear in the Glooko app, which patients can share with healthcare professionals for connected care in diabetes management.
The SoloSmart cap is currently undergoing integration with the Glooko platform and will gradually roll out across several countries starting later in 2023, with the combined solution being made available in English and local languages.
Once SoloSmart is integrated with the Glooko platform, SoloStar and DoubleStar pen users will have the ability to add the tracking of insulin dosing and timing to the functionality of Glooko to improve their insulin management and tracking and help visualize the correlation between insulin dose injected and blood glucose values.
The insulin tracking data can be linked to other important features of the Glooko mobile app like food tracking, exercise metrics, weight and blood pressure to create actionable insights to help people with diabetes approach care in an even more personalized way.
To read more, CLICK HERE